ARCHIVES

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Concept For studies Of Thorotrast Exposure

November 16, 1990

Post-Hoc Analysis of ThermoDox Suggests OS Improvement

January 31, 2014

Particle Radiation Working Group Asks Support For Facilities, Trials

June 23, 1978

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

NCI’s Kramer Named Director, NIH Medical Applications Office.

June 16, 2000